CTI Biopharma | CTIC - Sales Revenues


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

CTI Biopharma

CTI Biopharma reported $24.12M in Sales Revenues for its fiscal quarter ending in March of 2023.


Sales Change
Baxter International BAX:US USD 3.65B 238M
Bristol-Myers Squibb BMY:US USD 11.34B 69M
CTI Biopharma CTIC:US USD 24.12M 3.03M
Eli Lilly LLY:US USD 6.96B 341.8M
Geron GERN:US USD 21K 82K
Incyte Corp INCY:US USD 808.67M 118.03M
Mirati Therapeutics MRTX:US USD 7.17M 6.23M
Northwest Biotherapeutics NWBO:US USD 880K 283K
Novartis NOVN:VX USD 13.21B 207M
Novartis NVS:US USD 13.21B 207M
Plus Therapeutics, Inc. CYTX:US USD 506K 355K
Seattle Genetics SGEN:US USD 519.72M 8.43M